External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Leukemia & Lymphoma

Lymphoma is the most common type of blood cancer, with over 400,000 people diagnosed around the world each year.

It begins in a certain type of cell of the immune system (lymphocytes, or white blood cells) and can be divided into two main categories – Hodgkin lymphoma, and Non-Hodgkin lymphoma (NHL).

NHL is the more common of the two and can be further categorised as indolent (slow growing) or aggressive (fast growing), depending on the speed with which the cancer grows. Follicular lymphoma is the most common indolent form of the disease and diffuse large B-cell lymphoma (DLBCL) is the most common aggressive form.

Leukaemia is the second most common form of blood cancer, with over 300,000 people diagnosed globally each year. The type of leukaemia that a person has is dependent on which type of blood cell – white or red – becomes cancerous.

The four main types of leukaemia include acute lymphocytic leukaemia (ALL), chronic lymphocytic leukaemia (CLL), acute myeloid leukaemia (AML), and chronic myeloid leukaemia (CML).

Learn more about the latest advances in Roche lymphoma and leukaemia research.

What's new
Upcoming Congresses
Access to Roche and Genentech's medical information
View related congresses

Ask a question or share feedback